首页 > 会议日程详情
2025-11-22 星期六
10:30-12:00 705庐山
论文交流（英文）3
主持人

张磊 

东南大学附属中大医院

王夺 

东南大学附属中大医院

Atezolizumab plus Bevacizumab with or without Transarterial Chemoembolization as First-Line Treatment for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma: A Target Trial Emulation Study

邓力维  10:30-10:38

中国医学科学院肿瘤医院[论文发言]

Fruquintinib Combined with Sintilimab and TACE for Unresectable Hepatocellular Carcinoma: A Phase II Study

章浙伟  10:40-10:48

浙江省肿瘤医院[论文发言]

Application of evidence-based precision nursing under MDT framework in patients with broncho-biliary fistula after microwave ablation of liver cancer

蒋清玲  10:50-10:58

湖南省肿瘤医院[论文发言]

Prognostic Factors and Real-World Effectiveness of Second-Line Regorafenib After TKI Failure in Hepatocellular Carcinoma

严蓉  11:10-11:18

东南大学[论文发言]

Transarterial chemoembolization combined with systemic therapy versus transarterial chemoembolization monotherapy for unresectable, non-metastatic hepatocellular carcinoma: a meta-analysis and trial sequential analysis of randomized controlled trials

刘家曦  11:20-11:28

中国医科大学附属第一医院[论文发言]

基于大语言模型与检索增强生成的粒子植入计划自适应权重优化方法

肖卓  11:30-11:38

北京航空航天大学[论文发言]

Comparison of 125I Seed-Loaded Stents and Traditional Self-Expanding Stents in Patients Aged ≥75 Years with Malignant Esophageal Obstruction

李培顺  11:40-11:48

滕州市中心人民医院/滕州市人民医院 [论文发言]

MRI-Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization

王伟浪  11:50-11:58

东南大学附属中大医院[论文发言]